BioStock interview with Alligator CMO, Sumeet Ambarkhane.
Following the second round of interim results from OPTIMIZE-1, the phase 2 trial with mitazalimab in pancreatic cancer patients, BioStock reached out to Alligator’s CMO Sumeet Ambarkhane for an in-depth analysis.